Non-calcified arterial plaque is associated with diabetes, high systolic blood pressure and elevated “bad” cholesterol levels in asymptomatic individuals, according to a new study published online in the journal Radiology.
The Valley Hospital has been selected as the United States Coordinating Center for the international PRAETORIAN trial analyzing implantable cardioverter-defibrillators (ICDs). The trial will compare traditional ICDs with a newer model that may reduce the risk of complications associated with these otherwise life-saving devices.
Cincinnati Children’s Hospital Medical Center (CCHMC) has evaluated synthetic magnetic resonance imaging (MRI) on pediatric cases to study and clinically validate its use on children. Results from the first part of the evaluation, which used SyMRI software, shows the synthetic images are diagnostically satisfactory in comparison with conventional sequences.
According to a new report from BCC Research, the global market for disposable medical sensors grew to $4.2 billion in 2014 from $3.8 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 10.2 percent from 2014 to 2019, reaching $6.8 billion in 2019.
If you enjoy this content, please share it with a colleague
Long-term exposure to ionizing radiation is a primary occupational concern for today's interventional cardiologists. To address these concerns, many interventional cardiologists are enlisting the support of their hospital administrators to create workplace environments that reduce exposure to ionizing radiation.Â
If you enjoy this content, please share it with a colleague
Two all touch-screen interface Carestream Touch Ultrasound Systems have received U.S. Food and Drug Administration (FDA) 510(k) clearance and are now commercially available in the United States. The Touch Prime Ultrasound System and the Touch Prime XE Ultrasound System are both premium systems designed for general diagnostic imaging use in radiology.
Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps (IABPs) versus 40 cc IABPs in real-world clinical practice. The paper, titled "Hemodynamic Effects of Standard Versus Larger-Capacity Intraaortic Balloon Counterpulsation Pumps," appears in the April 2015 volume of The Journal of Invasive Cardiology.
If you enjoy this content, please share it with a colleague
Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k) clearance for its Enroute transcarotid neuroprotection system (NPS). The Enroute transcarotid NPS is used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while performing carotid angioplasty and stenting (CAS).